Merck & Co., Inc (MRK) July 20, 2021 Stock Price, Analysis & Forecast
Merck & Co., Inc (NYSE: MRK) opened the trading session on July 20, 2021, at $77.19, exhibiting a change of -1.1421% versus the previous close at $77.05. Within the trading session, the stock price jumped to $78.13 and decreased to $75.95. Finally, the stock arranged at $76.17. Nonetheless, given a longer-term approach, Merck & Co., Inc reported a 52 Week Range in the range of $67.26-$81.11.
Merck & Co., Inc's shares outstanding currently value $2.53B, in addition to a float of $2.51B. MRK operates in the LIFE SCIENCES sector of the PHARMACEUTICAL PREPARATIONS industry and has a market capitalization of $192.87B (as of July 20, 2021). Also worth noting that Merck & Co., Inc's 50-day Moving Average arranged at $76.31, while such marker as 200-day Moving Average is at the moment $74.42.
To assess the company's efficiency, let's observe Merck & Co., Inc's conglomerate performance. Currently, MRK has full-time employees. Merck & Co., Inc has generated $inf per worker Within the last fiscal year. In the meantime, MRK's income per employee was $inf. And now, let's observe the company's income report. Merck & Co., Inc's Net Income for the last fiscal year was $7.07B, while such marker as Income Before Taxes was at the level of $8.78B. MRK's Operating Income was at the mark of $-10,038,000,000.
Merck & Co., Inc (MRK) Earnings & Revenue
Talking about the Profitability, MRK reached a Profit Margin of 14.6% and an Operating Margin (TTM) of 31.4%. However, when we touch the questions of management effectiveness, Merck & Co., Inc generated a Return on Equity (TTM) of 26.4% and a Return on Assets (TTM) of 10.7%. A bit more income statements might bring clarity to our overview. According to the results of the latest quarter ended March 31, 2021, Merck & Co., Inc generated Revenue (TTM) of $48.02B, reporting a Quarterly Revenue Growth of 0.2%. As for the Revenue Per Share (TTM), this indicator was at the mark of $18.98. The company's Gross Profit (TTM) was $34.57B, while according to the EBITDA report, it was estimated at $18.59B.
Merck & Co., Inc (NYSE: MRK) Owners & Shares
Finally, let's take a look at the share statistics. As mentioned above, MRK's shares outstanding now amounts to $2.53B, where Shares Short was $23.93M versus the prior month amounted to $18.83M. (Short % of Float was 0.95%). And now, let's overview which kind of investors works with Merck & Co., Inc's stocks. MRK's current ownership accounts for 75.17% institutional investors, while 0.069% of shares belong to the insiders. Also worth mentioning some indicators affecting dividends & splits. Thus, MRK's Forward Annual Dividend Rate is currently at the mark of 2.6, whereas the Dividend Yield is 3.37%, and a Dividend Payout Ratio is 42.4% (Dividend Date: July 7, 2021). The company's Dividend Per Share marker thereby is $2.48.
MRK Trading Performance
It's time to observe the current performance indicators for Merck & Co., Inc. MRK's price/earnings to growth ratio during the last reported quarter was 1.66%. The company's PE Ratio stands at 27.51%, while MRK's Beta score is 0.417. Also worth noting that Merck & Co., Inc's Diluted EPS (Earnings per Share) trailing twelve months is at the mark of 2.769. Other valuable indicators are Price To Sales Ratio (TTM), which is currently recorded at 4.126, as well as Price To Book Ratio, which amounts to 7.33.
Merck & Co., Inc Analysis & Estimates
Within the previous 9-day period, Merck & Co., Inc's Average True Range (ATR) was 1.1649, while the stock's Stochastic SlowD moving average was 51.5430%, and the SlowK moving average volumed at 51.5430%.